Qanda

Cell & Gene Therapy Consulting · Accelerated by AI

Expert consulting for organizations building cell and gene therapy programs. Deep domain expertise combined with AI to deliver rigorous analysis at unprecedented speed.

Get in Touch Our Services

What We Do

Cell & Gene Therapy Consulting Services

From initial readiness assessment to first patient treated — we support every stage of your CAR-T or gene therapy program.

🏭

CAR-T Manufacturing Readiness

Facility gap assessments, GMP compliance review, and implementation roadmaps for point-of-care and centralized CAR-T programs including CliniMACS Prodigy.

📋

Regulatory & Clinical Strategy

IND preparation guidance, clinical development roadmaps, and regulatory strategy for novel CAR-T, TCR-T, and gene-edited cell therapy programs.

✅

Quality & GMP Operations

SOP development, quality management system design, and CAPA frameworks tailored to your manufacturing platform and regulatory jurisdiction.

🎓

Training & Onsite Implementation

Hands-on onsite training, staff capacity building, and implementation support from pre-clinical planning through first patient infusion.

💻

Clinical Data & Informatics

REDCap EDC design, clinical trial data workflows, and informatics strategy built for the complexity of cell therapy operations and long-term follow-up.

🔬

AI-Powered Strategic Analysis

Comprehensive literature reviews, competitive landscape analyses, and evidence-based reports with rigorous citations — delivered in days, not weeks.

How We Work

Our Approach

Expert knowledge meets modern AI tooling for faster, more rigorous consulting.

Understand

We start with your specific context — platform, team, regulatory environment, and strategic goals.

Analyze

AI-augmented analysis grounded in real-world cell therapy manufacturing, clinical trials, and regulatory experience.

Deliver

Actionable, prioritized recommendations — rigorously cited, practically framed, and ready to act on.

About Qanda

Built by a Cell Therapy Practitioner

Qanda was founded by Dr. Stephan Kadauke, physician-scientist and Associate Director of the Cell Based Therapy Laboratory at Children's Hospital of Philadelphia — one of the world's leading CAR-T programs.

With deep operational experience across manufacturing, clinical trials, and health informatics, Qanda brings CHOP-caliber expertise to programs worldwide — from established academic medical centers to emerging programs building their first CAR-T capability.

CAR-T Cell Therapy Point-of-Care Manufacturing CliniMACS Prodigy GMP Compliance IND Preparation FACT Accreditation Lentiviral Vector CD19 CAR-T Gene-Edited Cell Therapy Cell Therapy SOP Autoimmune Disease Clinical Trial Operations REDCap EDC Apheresis